The survival gap between wealthy and impoverished families is not just a feature of adult chronic disease — it shapes whether children born with structural birth defects live past their first decade. This large European analysis quantifies that gap with unsettling precision, and the magnitude of the disparity demands attention from both clinicians and public health planners.
Drawing on population-based registry data from ten congenital anomaly registers across seven European countries, researchers tracked 47,134 live-born children diagnosed with major congenital anomalies between 1996 and 2014. Socioeconomic status was defined using maternal education in four countries and national deprivation indices in two. Children in the most deprived group faced 47% higher mortality risk by age one compared to the least deprived (HR 1.47, 95% CI 1.19–1.83), a gap that widened dramatically to a twofold excess mortality risk between ages one and ten (HR 2.00, 95% CI 1.32–3.02). Children of non-EU nationals also showed elevated mortality rates, whereas single-mother status did not independently predict worse outcomes.
What distinguishes this analysis from prior work is its lifespan reach to age ten and its multinational scope, allowing cross-country variation to surface. The finding that SES disparities in post-infancy survival were statistically significant only in Ukraine and Wales hints at how national healthcare architectures mediate or amplify deprivation effects — universal access systems may attenuate, but do not eliminate, the gradient. The result also challenges the assumption that early surgical and neonatal interventions equalize outcomes: they appear to reduce but not close the gap in the first year, while post-infancy mortality diverges even further by deprivation level. Key limitations include heterogeneous SES definitions across registers, reliance on linked administrative data, and the observational design precluding causal inference. Still, for healthcare systems caring for children with congenital conditions, this is a clear signal that clinical excellence alone cannot substitute for socioeconomic equity in achieving survivorship.